<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0011009'>Acute</z:hpo> <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> normally suppresses hepatic <z:chebi fb="105" ids="17234">glucose</z:chebi> production (HGP) and gluconeogenic gene expression </plain></SENT>
<SENT sid="1" pm="."><plain>Conversely, <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> is accompanied by progressive increases in basal HGP and is a major contributor to <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> in both type 1 and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> by mechanisms that are poorly understood </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to investigate the molecular mechanisms whereby <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> contributes to excessive gluconeogenesis in Fao <z:e sem="disease" ids="C0019204" disease_type="Neoplastic Process" abbrv="">hepatoma</z:e> cells </plain></SENT>
<SENT sid="3" pm="."><plain>Increasing <z:chebi fb="105" ids="17234">glucose</z:chebi> from 5 to 20 mmol/l resulted in loss of <z:chebi fb="105" ids="17234">glucose</z:chebi> inhibition of PEPCK gene expression after 12 h </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, 24 h of incubation with 20 mmol/l <z:chebi fb="105" ids="17234">glucose</z:chebi> increased cAMP-stimulated PEPCK <z:chebi fb="2" ids="33699">mRNA</z:chebi> by approximately 40% (P &lt; 0.05) and similarly increased <z:chebi fb="105" ids="17234">glucose</z:chebi> production </plain></SENT>
<SENT sid="5" pm="."><plain>Although total CCAAT/enhancer-binding protein beta (C/EBPbeta) protein levels were suppressed, 20 mmol/l <z:chebi fb="105" ids="17234">glucose</z:chebi> increased the liver activating protein (LAP; an active isoform of C/EBPbeta)/liver inhibitory protein (LIP; an inhibitory isoform of C/EBPbeta) ratio significantly </plain></SENT>
<SENT sid="6" pm="."><plain>Chromatin immunoprecipitation studies of the endogenous PEPCK gene demonstrated an increased association of LAP with the cAMP response element of the promoter </plain></SENT>
<SENT sid="7" pm="."><plain>Using transient transfection to manipulate the LAP/LIP ratio, we also demonstrate a direct relationship between this ratio and PEPCK promoter activity </plain></SENT>
<SENT sid="8" pm="."><plain>An increased LAP/LIP ratio not only enhanced cAMP- and <z:chebi fb="0" ids="41879">dexamethasone</z:chebi>-induced PEPCK gene expression but also impaired the repressive effect of insulin </plain></SENT>
<SENT sid="9" pm="."><plain>These results demonstrate that sustained <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> diminishes the inhibitory effect of <z:chebi fb="105" ids="17234">glucose</z:chebi> and insulin on PEPCK expression and enhances hormone-stimulated PEPCK gene expression and hepatocellular <z:chebi fb="105" ids="17234">glucose</z:chebi> production </plain></SENT>
<SENT sid="10" pm="."><plain>Because prolonged <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> increases the LAP/LIP ratio and can potentiate hormone induction of PEPCK transcription, our results suggest that a <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo>-driven increased LAP/LIP ratio may be a critical molecular event in the pathogenesis of increased HGP in <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>